

Beschreibung
Throughout history, humanity has been plagued by a myriad of humanitarian crises that seemingly take the form of perpetual human suffering. Today, approximately 125,000,000 people require humanitarian assistance as the result of famine, war, geopolitical confl...Throughout history, humanity has been plagued by a myriad of humanitarian crises that seemingly take the form of perpetual human suffering. Today, approximately 125,000,000 people require humanitarian assistance as the result of famine, war, geopolitical conflict, and natural disasters. A core component of this suffering is afflictions related to human health, where disturbances strain or overwhelm the existing healthcare infrastructure to create the conditions for an increase in morbidities and co-morbidities. One of the more startling elements is the loss of life to preventable medical conditions that were not properly treated or even diagnosed in the field, and is often due to the limited interventional capacity that medical teams and humanitarian practitioners have in these scenarios. These individuals are often hindered by medical equipment deficiencies or devices not meant to function in austere conditions.
The development of highly versatile, feasible, and cost-effective medical devices and technologies that can be deployed in the field is essential to enhancing medical care in unconventional settings.
In this book we examine the nature of the creative problem-solving paradigm, and dissect the intersection of frugal, disruptive, open, and reverse innovation processes in advancing humanitarian medicine. Specifically, we examine the feasible deployment of these devices and technologies in unconventional environments not only by humanitarian aid and disaster relief agencies, but also by crisis-affected communities themselves. The challenge is complex, but the financial support and technical development of innovative solutions for the delivery of humanitarian aid is a process in which everyone is a stakeholder.
This book promotes the promise that introducing technological innovations into humanitarian crises can reduce the cost of care and improve health outcomes. this thin and thoughtful volume could be useful to students interested in learning more about the potential of innovative, disruptive technologies in humanitarian settings. (Dilshad Jaff, Medicine, Conflict and Survival, Vol. 35 (1), 2019)
Autorentext
Krish W. Ramadurai is a DPhil student in the Department of Engineering Science at the University of Oxford, a member of St. Hilda's College, and a member of the Multimodal Medical Data Integration & Analysis (MultiMeDIA) Lab at the Institute of Biomedical Engineering (IBME). His research focuses on developing multi-modal AI frameworks for drug development, leveraging hybrid mechanistic-AI models and functional modeling approaches to enhance the translatability and efficacy of next-generation therapeutics. Krish is also a Partner at AIX Ventures, where he oversees technical diligence, deal sourcing, and portfolio operations across the firm's artificial intelligence, healthcare, and life sciences practices. He has led and managed over 45 early- and growth-stage investments, generating a cumulative portfolio enterprise value exceeding $20 billion across multiple top-decile performing funds. Krish has directly supported over 25 pioneering scientific advancements, including the world's first AI-designed drug to enter human clinical trials and the first therapeutic discovered using a 3D-bioprinted tissue model. Additionally, he is a Harvard- and Oxford-trained scientist and biomolecular engineer, and a former researcher at Harvard University and MIT. At Harvard's Belfer Center for Science and International Affairs and the Taubman Center for State and Local Government, he collaborated closely with former United States Secretary of Defense, Dr. Ash Carter, and Nobel Laureate Economist Dr. Michael Kremer, notably contributing to USAID's Development Innovation Ventures Fund. Krish has authored several books on applied engineering and medicine featured by Barnes & Noble, the National Institutes of Health, and leading university libraries worldwide. Krish has served as chairman, director, and board member for over a dozen leading AI companies. He has advised numerous initiatives, including Nucleate, the Defense Innovation Unit (DIU), and the Defense Advanced Research Projects Agency (DARPA). His thought leadership has been featured in leading global media outlets, including The Wall Street Journal, Venture Capital Journal, Yahoo Finance, TechCrunch, Business Insider, Axios, the World Economic Forum, and Nikkei Asia. Abhirup Banerjee is a Royal Society University Research Fellow and Principal Investigator at the Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford. His research lies at the intersection of cardiovascular science, artificial intelligence, and computational modelling, with a focus on digital twins, geometric machine learning, and multimodal data integration for cardiac diagnostics and interventions. He leads the Multimodal Medical Data Integration & Analysis (MultiMeDIA) Lab, where his team develops personalised, predictive models of cardiac anatomy and function using large-scale imaging and physiological datasets. A key aspect of his work involves reconstructing patient-specific 3D/4D cardiac structures from coronary angiography, cardiac MRI, and ECG. His AI-driven pipelines for coronary reconstruction, infarction modelling, and atrial fibrillation mapping are designed for real-time clinical use and have been patented in collaboration with Oxford University Innovation. Dr Banerjee’s approach to cardiovascular science is rooted in the application of advanced computational methodologies, including variational autoencoders, point cloud networks, graph-based attention models, and statistical shape analysis. His work exemplifies a commitment to interdisciplinary innovation, translating cutting-edge algorithms into clinically meaningful tools. He has authored over 80 peer-reviewed publications and serves on the Editorial boards of several international journals. His research has been widely presented at leading scientific meetings, contributing to the advancement of data-driven approaches in cardiovascular medicine. He is also activ
Inhalt
The Humanitarian Relief Paradigm.- Current Humanitarian Crises: Defining the Humanitarian Aid Complex.- Medical Treatment in Unconventional Settings: Meeting the Needs of Conflict Victims.- Health Is Wealth: Avoiding Chronic Illness as a Perpetuity.- The Humanitarian Paradox: What Happens When We Leave?.- Disparities of Healthcare Services in Conflict Areas.- Humanitarian Innovation and Frugal Engineering: A Social Perspective.- Humanitarian Innovation and Medicine: Defining the Innovation Process.- Adapting Innovation Sub-Types in Humanitarian Medicine: Turning the Unconventional into Conventional.- Frugal Innovation Sub-Types in Health and Medicine.- Contextualized Adaptations.- Bottom-Up.- Lean Tools and Techniques.- Opportunistic Solutions.- Disruptive Innovation: The Real Meaning.- Open and Reverse Innovation + Crowdsourcing and Wikicapital: The Future of Creative Problem-Solving.- Frugal Medical Technologies and Adaptive Solutions: Field-Based Applications.- Enhancing the Interventional Capacity of Humanitarian Practitioners, Community Health Workers, and Crisis-Stricken Communities.- Scaling Adaptive Solutions in the Humanitarian Field.- Surgical Care and Prosthetics.- Neonatal and Maternal Conditions.- Infectious Diseases.- Disruptive Technologies and Innovations in Aid and Disaster Relief: An Integrative Approach.- Data Collection and Crisis Management: Crowdsourced Crisis Mapping.- Robotics and Wearable Technology.- mHealth, Telehealth, and Blockchain.- Humanitarian Innovation in the Modern Era: Ending Human Suffering.- Reworking Knowledge Transfer in the Humanitarian Ecosystem: Empowering Conflict Victim and Refugee Innovation.- The Future of Humanitarian Medicine and Creative Problem-Solving.